NEW YORK, Oct. 11, 2018 — Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
AbbVie Inc. (NYSE: ABBV) Class Period: October 25, 2013 – September 18, 2018 Lead Plaintiff Deadline: November 20, 2018 Join the action: https://www.zlk.com/pslra-1/abbvie-inc-loss-form?wire=3
The lawsuit alleges: AbbVie Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) AbbVie’s strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
To learn more about the AbbVie Inc. class action contact [email protected].
MGT Capital Investments Inc. (OTCMKTS: MGTI) Class Period: October 9, 2015 – September 7, 2018 Lead Plaintiff Deadline: November 27, 2018 Join the action: https://www.zlk.com/pslra-1/mgt-capital-investments-inc-loss-form?wire=3
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
The lawsuit alleges: MGT Capital Investments Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Defendants were engaged in an illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (2) the “Scheme Defendants”–Defendants Ladd, Honig, Stetson, Brauser, O’Rourke, and Groussman–had a history of engaging in illegal conduct in connection with the purchase and sale of securities; (3) the Scheme Defendants were a “group”, pursuant to Section 13 of the Exchange Act; (4) the Scheme Defendants exercised control over the Company; (5) the Company’s acquisition of D-Vasive Inc. was part of Defendants’ illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (6) Defendants’ illicit scheme caused MGT Capital to make false and misleading statements, which would result in governmental and regulatory scrutiny; (7) the scheme would result in the delisting of MGT Capital’s stock from NYSE MKT; and (8) as a result, Defendants’ statements about MGT Capital’s business and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the MGT Capital Investments Inc. class action contact [email protected].
Stitch Fix, Inc. (NASDAQ: SFIX) Class Period: June 8, 2018 – October 1, 2018 Lead Plaintiff Deadline: December 10, 2018 Join the action: https://www.zlk.com/pslra-1/stitch-fix-inc-loss-form?wire=3
The lawsuit alleges: Stitch Fix, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) Stitch Fix’s active client growth had slowed to a crawl; (2) Stitch Fix had completely shut down its television advertising campaign for 10 of the 13 weeks in fourth quarter 2018, dramatically decreasing the number of new active client additions; and (3) as a result, the Company’s current business metrics and financial prospects were not as strong as it had led the market to believe during the Class Period.
To learn more about the Stitch Fix, Inc. class action contact [email protected].
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.